| 摘要 |
medicine. SUBSTANCE: method involves administering effective dose of hydrocortisone agonist to a patient. Hydrocortisone contents is determined to evaluate inhibiting effectiveness of the hydrocortisone agonist exerted upon hydrocortisone autoproduction. Hydrocortisone autoproduction inhibition being below norm, metabolic syndrome or state related to it is considered to be the case. EFFECT: enhanced effectiveness of early stage diagnosis. 11 cl, 2 dwg
|
